Abstract To determme whether the sympathetic nervous system contnbutes to the hypertension induced by long-term suppresslon of mtnc oxide synthesis, we determined the neurally induced changes In renal excretory function durmg chronic admnnstratlon of NC-nltro-r.-argnune methyl ester (L-NAME) Studies were carried out m SIX conscious chromcally Ins&u-mented dogs subJected to umlateral renal denervatlon and surgical dlvlslon of the urmary bladder Into two hemlbladders to allow separate 24-hour urine collection from denervated and mnervated ludneys Animals were studied during acute (100 mmutes) and chronic (5 days) intravenous infusion of L-NAME at 37 1 nmol/kg per tnmute (10 pg/kg per mmute) During the first 100 minutes of L-NAME, there were no significant changes in mean arterial pressure (control 9623 mm Hg), but heart rate fell from 66?6 to 55-t-7 beats per minute Changes m glomerular filtration rate were not significant, but renal plasma flow and unnary sodium excretion decreased to =75% and 50% of control values, respectively, however, these changes were comparable In both kidneys In assoclatlon with these responses, plasma con-N ltrlc oxide has a number of effects that Impact on the regulation of renal function and arterial pressure 1.2 NO 1s a highly labile substance formed m a number of tissues by enzymatic conversion of the endogenous substrate L-argmme 3 The conversion of L-argmme to NO 1s mediated by a family of related enzymes known as NOS. The influence of endogenous NO production on physlologlcal processes has been assessed by the systemic admuustratlon of L-argmme analogues such as L-NAME, which competltlvely mhlblt NO synthesis. Acute admmlstratlon of L-NAME increases arterial pressure and vascular resistance, actions attributed to dlmmlshed production of endothehal NO Chronic treatment with L-NAME leads to sustained hypertension, but the mechanisms that mediate this response have not been fully elucidated NOS lsozymes are present m the bram,3-5 and NO appears to be an important neural modulator m brain regions involved in the autonomic regulation of circulatory and renal function. Specifically, acute studies m anesthetized animals have demonstrated that mJectlon of NO synthesis antagonists directly mto either the rostra1 ventrolateral medulla6 or the nucleus tractus sohtanus7 causes mcre- Key Words l mtnc oxide l hypertension l renal nerves l sympathetic nervous system l L-NAME ments m arterial pressure and marked activation of the efferent renal sympathetic nerves. Similarly, either mtravenous* or mtraclsternaly mhlbltlon of NO increases arterial pressure and efferent renal sympathetic nerve actlvlty Therefore, since acute activation of the renal nerves promotes sodium retention, a number of mvestlgators have hypothesized that the renal nerves play an Important role m mediating the hypertension induced by chronic mhlbltlon of NO synthesis Indeed, recent studies m the rat have shown that either chronic renal denervatlonl0 or chenncal sympathectomyl' delays or reduces the severity of L-NAME-mduced hypertension Studies m conscious chronically instrumented dogs have not elucidated the role of the renal nerves m medlatmg L-NAME-induced hypertension. Whereas one study indicates that the sympathetic nervous system contributes importantly to the acute antmatrmretlc effects of L-NAME infusion, 12 another falls to support the concept advanced m rat studies that the renal nerves contribute importantly to the hypertension caused by chronic blockade of NO synthesis 13 One interpretation of the data from experiments m dogs 1s that L-NAME admmlstratlon produces acute but not chronic actlvatlon of the sympathetic nervous system. However, there have been no studies m any species that have determined the time-dependent changes m neurally induced sodmm retention during L-NAME admmlstration.
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We tested the hypothesis that increments m renal sympathetic nerve activity decrease renal excretory function both acutely and chronically during L-NAME admmls- Selected Abbreviations and Acronyms GFR = glomerular filtration rate L-NAME = NC-mtro-L-argmme methyl ester MAP = mean arterial pressure NO = mtnc oxide NOS = NO synthase PRA = plasma rerun actlvlty RPF = renal plasma flow tratlon and therefore play an important role m medlatmg hypertension induced by chronic blockade of NO synthesis This was achieved by determining the acute and chronic effects of L-NAME mfuslon on renal excretory function m unilaterally denervated dogs m which the unnary bladder had been surgically divided mto two hemlbladders to allow the separate collection of urine from each kidney. Smce the innervated and denervated ludneys of each animal were subjected to the same level of arterial blood pressure and circulating factors, any difference m renal excretion between the innervated and denervated kidneys would be attnbutable to the direct mfluence of the renal nerves. Fmally, to provide insight into global changes m activity of the sympathetic nervous system dunng NO synthesis inhibition, circulating levels of plasma catecholammes were determined dunng acute and chronic L-NAME admmistration.
Methods Animal Preparation
Studies were carrled out m SIX female mongrel dogs and all procedures were carried out m accordance with mstltutional and NIH gmdehnes regarding the use of laboratory animals Dogs were sedated with acepromazme (0 2 mg/kg) and anesthetized with pentobarbltal so&urn (30 mg/kg IV) Usmg aseptic techmques, we implanted Tygon catheters (0 05 m ID, 0 09 m OD, Norton Plastics) m the femoral arteries and veins and extenonzed between the scapulae The left kidney was denervated via a flank mclslon 14 The renal artery and vem were stnpped of all visible nerves and adventitla, and pamted with a solution of 10% phenol m absolute ethanol for ~20 minutes Subsequently, the urinary bladder was exposed via a suprapubic 1nClSlon and surgically divided mto two hermbladders with a sihcone elastomer catheter implanted m each hermbladder as previously described 14 The catheters were exteriorized m the flank region and connected to sterile plastic bags The urine collection bags were changed daily and the femoral catheters were flushed two to three times weekly with lsotomc saline and filled with hepann (1000 U/mL) After a l-week convalescence period, the dogs were placed m metabolic pens m a room mamtamed at 2253°C with a 12/12 hour light-dark cycle and fitted with an alummum and canvas backpack containing a pressure transducer (model P23 ID, Statham Laboratones, Inc) positioned at heart level 1415 Pressure transducer cables and the infusion hnes were brought to the top of the cage through a flexible tube attached to the top of the backpack Isotonic saline (a350 mL/d) was infused contmuously mto a venous catheter with a Sage tubing pump (model 375A Sage Instruments) A disposable Mdhpore filter (Cathlvex MIhpore) was connected m series with each mfuslon hne to prevent passage of bacteria and other contammants The dogs were given free access to water and maintained on a fixed dally &et of two 15 S-oz cans of prescnptlon heart &et (H/D, Hills Pet Products, Inc) supplemented with 5 mL vitamin syrup (VAL Syrup, Fort Dodge Laboratones) Two cans of I-I/D provide <lO mmol sochum and =60 mmol potassium Thus, with the saline infusion, sochum intake was ~~60 mmol/d Water consumption was monitored, and 24-hour urine samples were taken at a0930 hours Rectal temperature was monitored daily to venfy that the animals were afebnle, and amoxicdhn (250 mg BID, Warner Chilcott Laboratories), chcloxicilhn (250 mg BID, Bnstol Laboratories), and a trlmethopnm (400 mg) and 3ulfamethoxazole (80 mg) combination (Sulfatnm, BID, Schem Pharmaceutical, Inc) were given prophylactically Throughout the study, arterial pressure was recorded from a femoral arterial catheter connected to the pressure transducer and a Grass polygraph (model 7D, Grass Instruments) A mlcrocomputer and customized software 16 were used to sample the signal from the Grass recorder at 200 Hz for a duration of 12 seconds, once a minute, 24 hours a day The digitized data for each 12. second burst were lmmedlately processed to compute MAP and heart rate The daily values for MAP and heart rate were determmed from the average of the 1110 sample points collected durmg the 18 5-hour penod between 1 AM and 7 30 AM The hours excluded from the 24-hour analysis Included the time required for cahbratlon of pressure transducers, measurement of renal function (on selected days), feeding, and cleanmg of cages
Experimental Protocol
Before the control period, the dogs were conditioned to the daily regimen dunng a trammg and eqmhbratlon penod that lasted =7 days Durmg this time they were tramed to he qmetly on the cage floor for the measurement of renal function and for the collection of arterial blood samples After a 3-day control period, the dogs were continuously infused with L-NAME for 5 days at 37 1 nmol/kg per mmute (10 pg/kg per mmute) to mhltnt synthesis of NO Renal hemodynamlcs and renal excretory functlon were assessed twice durmg the control period, on day 5 of L-NAME, and several days after the mfuslon was terminated Addmonally, the tramlent renal response to L-NAME was measured for an additional five clearance penods during the first 100 mmutes of L-NAME mfuslon GFR and RPF were estimated from the clearances of [ '251]lothalamate (Glofil, Isotex Diagnostics) and [ '3'I]lodohppurate (I-hppuran, Syncor International Carp), respectively, as previously described 1415 Durmg each expenment, the results of three consecutlve 20-mmute clearance penods were averaged to detemune the GFR and RPF At the end of the clearance penods, each henubladder was flushed twice with a total of 20 mL of stenle dlshlled water and the wash was added to the unne collected A 1 5-mL artenal blood sample was taken at the nudpomt of each clearance penod for determmanon of the plasma concentrations of ['251]lothalamate and [ '3'I] iodohlppurate Before each renal clearance study and on mternuttent days throughout the control, experimental, and recovery penods, 8-mL arterial blood samples were collected for measurement of hematocnt, PRA, and the plasma concentrations of norepmephnne, epmephrme, sodmm, potassmm, and protein Blood samples were taken after the dogs had been m a recumbent position for a45 mmutes, and after MAP and heart rate were stable Analytical Methods PRA was measured by radlolmmunoassay 17 Plasma and urme concentrations of sodium and potassium were determined by flame photometry (IL 943, Instmmentatlon Laboratories), plasma protein concentration by refractometry (American Optical), and hematocnt by a micromethod (Autocnt II, Clay Adams) The plasma concentrations of norepmephrme and epmephrme were determined by high-performance hqmd chromatography as previously described 18 Addmonally, renal norepmephrme concentratlon was determined m four dogs by methods previously employed m our laboratory '4 Statistical Analysis Results Acute Responses to L-NAME Durmg the first 100 minutes of L-NAME mfunon, there were no significant changes m MAP but heart rate decreased. Moreover, there were progressive reductions m RPF and urinary sodmm excretion, however, the responses were quantitatively similar m both ludneys Maximum reductions m RPF and urinary so&urn excretion (to =75% and 50% of control, respectively) occurred during the last clearance period (after 80 to 100 minutes of L-NAME mfusion) and are illustrated m the Table. Although RPF decreased acutely, there were no significant changes m GFR dunng the first 100 minutes of L-NAME Infusion, and consequently increments in filtration fraction were comparable m each kidney Potassmm excretion tended to decrease m both kidneys (=20%), but the changes were not statistically significant Anally, there were no slgnlficant changes m PRA or m the plasma concentrations of norepmephrme, epmephrme, protein (control 6 7+-O 4 mg/dL), sodmm (control. 145% 1 mmol/L), potassmm (control 4 420 1 mmol/L), or hematocnt (control 3853) durmg the first 100 minutes of L-NAME mfuslon Plasma levels of catecholammes chd tend to fall during acute mfusion of L-NAME, but these responses were not quite statistically significant (P= 07) Chronic Responses to L-NAME Changes m MAP, heart rate, and dally unnary sodium excretion durmg chronic mfuslon of L-NAME are summarized m Fig 1 Although MAP failed to increase durmg the first 100 minutes of L-NAME, elevations m MAP occurred later m the day On day 1, MAP increased from 92~3 to 10724 mm Hg, and tlus increase was sustained throughout the 5-day infusion period of L-NAME The hypertension was associated with a pronounced bradycardla; on day 5, heart rate was reduced from a control value of 72-t-4 to 5725 beats per minute Although urinary sodium and potassmm excretion decreased during acute administration of L-NAME, there were no significant changes m the urinary excretion of these electrolytes (control* sodium, 6425 mmol/d; potassmm, 5523 mmol/d) on day 1 or on any subsequent day of L-NAME mfuslon Most importantly, the renal nerves did not influence sodium excretion during L-NAMES-induced hypertension. As shown m Fig 2, rates of urinary sodium excretion were comparable m innervated and denervated kidneys durmg chronic infusion of L-NAME, as well as durmg the control and recovery periods 'This IS also reflected by slmllar denervated-to-innervated kidney ratios for urinary so&urn excretion throughout the study (Fig 2) The apparent mcrease m the ratio on day 2, suggesting neurally induced sodium retention, was not statistically significant and was primarily influenced by one dog that excreted low amounts of sodium (~8 mmol) on this day.
The chrome effects of L-NAME on renal hemodynam-ICS are summarized m Rg 3. Although RPF decreased and filtration fraction increased during acute infusion of L-NAME (Table) , these changes were not sustained chronically; GFR, RPF, and filtration fraction were not sig- mficantly different from control values on day 5 of L-NAME or during the recovery period. Fig 4 illustrates that there were no stgmficant changes m either plasma norepmephrme (control: 845-t 136 pmol/L or 143223 pg/mL) or epinephrme (control* 557 -+ 115 pmol/L or 87t 18 pg/mL) concentration, suggesting a lack of general sympathettc stimulation during chronic L-NAME mfusion Also, PRA (control 0 40~0 13 nmol angtotensm I per liter per hour or 0.620.2 ng angtotensm I per millihter per hour), hematocrrt (control 38+3), and the plasma concentration of protein (control 6.7?0 4 mg/dL), sodium, and potassium were unchanged durmg chronic L-NAME infusion Finally, as m a recent mvestrgation from our laboratory employmg the exact same experimental preparation, 14 there was more than a 30-fold difference m norepmephrme content between innervated and denervated kidneys, mdicatmg pronounced depletion of norepmephrme m the denervated kidneys In accordance with this earlier study, norepmephrme concentration in the denervated kidneys (112&53 fmol/mg tissue or 19k-9 pg/mg tissue) was <118 fmol/mg tissue (<20 pg/mg tissue)
Discussion
Although the mechanisms have not been fully elucidated, numerous studies have shown that chronic blockade of NO synthesis produces hypertension r2.1320 Our results confirm these observations, but they provide no support for the concept that the hypertension IS mediated by the sympathetic nervous system Plasma levels of catecholammes, an mdex of global sympathetic activity, did not increase during chronic L-NAME-mduced hypertension and, more importantly, the renal nerves did not promote sodium retention.
Acute blockade of NO synthesis produces a number of changes m renal function which could contribute to the development of chronic hypertension, however, the importance of these effects m mediating L-NAME-induced hypertension 1s unclear. Several studies, including the present, have shown that acute blockade of NO synthesis decreases sodium excretion in association with reductions m renal blood flow and increments m filtration fraction 1 1221-23 Whtle such hemodynamic responses may tmpair pressure natrmresrs acutely, in the present study they were not sustained chromcally. As reported by others,'2 RPF and filtration fraction returned to control levels during chronic L-NAME infusion Thus, although the mamtenance of sodium balance despite sustained elevations m arterial pressure indicates a hypertensive shift m the pressure natrmresis relattonshtp durmg L-NAME admmistratton,24 the causal mechanisms that contribute to impaired renal excretory function are not apparent.
Previous acute studies m anesthetized animals have advanced the concept that neuronal as well as endothehal NOS may contribute to the tonic regulation of vasomotor tone and arterial pressure InJectron of NO synthesis antagonists directly into either the rostra1 ventrolateral medulla or the nucleus tractus sohtarms7 causes increments m arterial pressure and marked activation of the efferent renal sympathetic nerves, while intravenous8 or mtracisternal mhibmon of NO leads to similar changes m arterial pressure and renal nerve acttvtty These acute studies and others2 have led to the hypothesis that increments m sympathetic outflow mediate, at least m part, the hypertensive response to chrome L-NAME admmistration If sustained increases m sympathetic outflow were directed to the kidneys during chrome mhrbitton of NO synthesis, then a neurally dependent reduction m renal excretory function could contribute to the hypertensive shift m the pressure natrruresrs relattonshtp.i5 Indeed, a recent study by Matsuoka et al lo m the rat suggests that renal denervatton delays the onset of L-NAME-induced hypertension, at least as assessed by indirect tall-cuff measurements of blood pressure However, direct measurements of arterial pressure from arterial catheters mdmated that the chrome hypertensive response to L-NAME was not srgmficantly influenced by the renal nerves after 5 weeks of treatment A more recent study m which chronic chemical sympathectomy markedly attenuated L-NAME-induced hypertension m rats supports a more general role for the sympathettc ner- vous system m mediating this form of hypertension m rodents ii The present study m conscious chromcally instrumented dogs fatls to support the notton that NO normally restrams central sympathetic outflow. Durmg acute mfusion of L-NAME, there was no sigmficant increase m arterial pressure, but there were reductions m heart rate and m plasma levels of catecholammes Although the decrease m plasma norepmephrme concentration did not quite achieve statistical stgmficance (P= 07), taken together our results suggest that acute increments m arterial pressure were not discernible because of reflex mechanisms that mhibited central sympathetic outflow Thus, our findings are consistent with the results of Hansen et al 25 These mveshgators recorded muscle sympathetic nerve activity m humans during a 1.5~mmute mfusion of the NO synthesis mhibitor, NC-monomethyl-L-argmme. In this study, blockade of NO synthesis did increase arterral pressure 10 mm Hg, but this response was associated with bradycardia and a decrease m sympathetic nerve activity Furthermore, since there were comparable reductions m unnary sodium excretion m innervated and denervated kidneys m the present study during acute L-NAME mfusion, our findmgs indicate that the renal nerves were not selectively activated at a time when sympathetic acttvity to the remamder of the body was decreased
The results of the present study suggest that the sympathetic nervous system and more specifically the renal nerves do not contribute appreciably to either the acute or chronic phases of L-NAME-induced hypertension In the present study, there were no significant increments m plasma levels of catecholammes at any time during chronic L-NAME admmistration, suggesting that the hypertension was not sympathetically mediated. Moreover, there were no significant differences m urinary sodmm excretion between innervated and denervated kidneys throughout the en&e S-day period of NO mhibition This strongly mdicates that sodium retention was not mediated by increased renal nerve activity and therefore is consistent with a recent study which demonstrated that the severity of hypertension m response to chronic L-NAME mfusion was the same m dogs with bilateral renal denervation as it was m dogs with intact renal mnervation 13
It should be emphasized that a novel aspect of the preparation used m the present study is that both the innervated and denervated kidneys share a common blood supply Thus, any differential response m renal excretory function between the kidneys cannot be caused by subtle changes m arterial pressure or cnculatmg factors This is not the case m experiments comparmg responses m either renal denervated or sympathetically blocked animals to responses in intact controls
The possibrlity should be considered that potential differences m sodium excretion between innervated and denervated kidneys were masked by supersensmvrty of the denervated kidneys to cnculatmg norepmephrme However, it is important to note that renal denervation supersensmvity has been demonstrated only when plasma levels of norepmephrme have exceeded those that would be expected under physiological or pathophysiological conditions 26 Furthermore, m recent unpublished studies we have observed that chronic (5 days) intravenous mfusron of norepmephrme at 148 pmol/kg per minute (25 rig/kg per minute), a rate which produced approximately a sevenfold increase m plasma norepmephrme concentration, had no effect on the relative excretion rates of sodmm between innervated and denervated kidneys Thus, it is unlikely that at the prevailmg plasma levels of norepinephrme m the present study, supersensitrvity of the renal vasculature or tubules of chronically denervated kidneys accounts for the fact that there were no differences m sodium excretion between the two kidneys In concluston, these studies performed m conscious chromcally instrumented dogs mdicate that the hypertension produced by chronic blockade of NO synthesis is not assocrated with long-term changes m whole-kidney hemodynamics. Moreover, these studies fail to support the hypothesis that the sympathetic nervous system, and more specifically, the renal nerves contribute sigmficantly to the long-term increments m arterial pressure produced by the chronic admmistration of L-NAME 
